News Archive

Becton, Dickinson and Company (BD) has launched shortest ever insulin syringe needle for the first time in Hyderabad. The needle is 25 per cent shorter than the contemporary needles available in the market.

BD, a leading global medical technology company, has launched BD Glide 6mm needle, the smallest ever insulin syringe needle developed with TBL technology for the first time in India. The needle has been designed to improve patient comfort. Compared to present needle size, 80 per cent patients have preferred this new needle.

For six years, green energy business Clean Currents made the Rockville Innovation Center above the downtown Rockville library its home.

The company enjoyed reduced costs for spaces and certain services than it would have had in the general private market. It had access to shared conference rooms, administrative help, a kitchen and copy machine, all pretty much financed by Montgomery County.

Venture capitalists invested $1.12 billion to U.S. mobile companies in last quarter, making it the biggest venture capital financing quarter in history for this sector.

Q3 also had the highest number of mobile deals ever in a quarter, and it was the first time mobile VC deal share eclipsed the healthcare sector, according to a study by CB Insights. 

I think few things could be more rewarding than investing in a company that develops a cure or effective treatment for any of the hundreds of conditions that affect millions of people with no effective treatment. But finding the right company can be fraught with risk. That’s one reason why angel and venture investors have been allocating funds to later stage companies that carry less risk.

Luke Timmerman of Xconomy and David Sable, the portfolio manager for the Special Situations Funds, each compiled a handy list of red flags that should make prospective investors in startup life science companies pause. Here are six of them.

Between October 1 and 17, the federal government ceased all nonessential operations because of a partisan stalemate over Obamacare. Although it is premature to declare this the greatest example of misgovernance in modern U.S. Congressional history, this impasse ranks highly.

One casualty of the showdown was any consideration of changes to lessen the impact of the across-the-board sequestration cuts that began on March 1. The cuts have caused economic and other distress across the nation, including serious impacts within the health care sector. Nearly eight months into sequestration, we can move beyond predictions and begin to quantify these effects.

Venture capital deals in the Greater Baltimore area jumped in the third quarter, as investors poured money into medical device makers, biotech firms and one of the region’s largest money managers.

VC firms invested $445.7 million in 53 companies in the Baltimore-Washington area in the three months ended Sept. 30. That was up from $420 million invested in 30 companies in the second quarter and the highest level in almost six years, according to the MoneyTree report from PricewaterhouseCoopers and the National Venture Capital Association. The report uses data from Thomson Reuters.

Every country, every government, every population is a participant in a global trial and error. Each one faces different circumstances and, therefore, approaches healthcare differently.  But, as world health leaders see it, everyone can learn from others’ struggles and successes to improve and simplify their respective strategies. Health information technology is at the core.

Finding the global lessons from local healthcare strategies facilitates progress toward Universal Health Coverage, or UHC, a public health concept championed notably by the World Health Organization and it’s director, Margaret Chan. According to Najeeb Al-Shorbaji, director of knowledge, management, and sharing at the WHO, in a statement released to Healthcare IT News, WHO defines UHC as “all people receiving quality health services that meet their needs without exposing them to financial hardship in paying for them.”  

Join BioBuzz and their sponsor Fujifilm Diosynth Biotechnologies along with many others from the local biotech industry at another exciting BioBuzz event on October 30th from 4:30 – 7:00 p.m. in Gaithersburg at Growlers in Old Towne Gaithersburg!

Click the link to learn how to win a FujiFilm Camera!